Insider · CIK 0001814883

Ozden Rabia Gurses

Reports to the SEC for 3 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001814883

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-09	Adverum Biotechnologies, Inc.U Disposition from Tender	Chief Medical Officer	UDisposition from Tender	−8,125 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.A Award	Chief Medical Officer	AAward	+85K sh	—	—	85,000
2025-12-09	Adverum Biotechnologies, Inc.U Disposition from Tender	Chief Medical Officer	UDisposition from Tender	−85K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−8,000 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−4,000 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−85K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−44K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−48.8K sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−8,000 sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+8,000 sh	—	—	8,000
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−4,000 sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+4,000 sh	—	—	4,000
2025-02-25	Adverum Biotechnologies, Inc.A Award	Chief Medical Officer	AAward	+8,125 sh	—	—	8,125
2025-02-25	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+48.8K sh	—	—	48,750
2024-08-02	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+44K sh	—	—	44,010
2024-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+85K sh	—	—	85,000
2024-02-05	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Medical Officer	SSale	+6,346 sh	$4.86	+$30.8K	153,054
2024-02-03	OCULOCULAR THERAPEUTIX, INCA Award	Chief Medical Officer	AAward	+66.6K sh	—	—	159,400
2024-02-03	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+200K sh	—	—	200,000
2024-01-31	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Medical Officer	SSale	−7,764 sh	$4.95	−$38.4K	92,767
2023-07-07	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Medical Officer	SSale	−832 sh	$4.93	−$4,101.76	100,531
2023-06-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+40K sh	—	—	40,000
2023-02-06	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Medical Officer	SSale	−6,416 sh	$4.24	−$27.2K	101,363
2023-01-30	OCULOCULAR THERAPEUTIX, INCA Award	Chief Medical Officer	AAward	+55.6K sh	—	—	107,779
2023-01-30	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+167K sh	—	—	166,667
2023-01-30	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000
2022-07-14	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+10K sh	—	—	10,000
2022-07-01	OCULOCULAR THERAPEUTIX, INCA Award	Chief Medical Officer	AAward	+6,667 sh	—	—	52,223
2022-07-01	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+20K sh	—	—	20,000
2022-07-01	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+20K sh	—	—	40,000
2022-03-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+80K sh	—	—	80,000

Recent filings

Accepted (ET)
Dec 104
Ozden Rabia Gurses0001814883-25-000005
SEC(opens sec.gov)
Jun 204
Ozden Rabia Gurses0001415889-25-017864
SEC(opens sec.gov)
Feb 274
Ozden Rabia Gurses0001415889-25-005834
SEC(opens sec.gov)
Aug 64
Ozden Rabia Gurses0001415889-24-020827
SEC(opens sec.gov)
Jun 204
Ozden Rabia Gurses0001415889-24-017681
SEC(opens sec.gov)
Feb 64
Ozden Rabia Gurses0001104659-24-011197
SEC(opens sec.gov)
Feb 24
Ozden Rabia Gurses0001104659-24-010237
SEC(opens sec.gov)

Companies

Address

C/O ADVERUM BIOTECHNOLOGIES, INC. 100 CARDINAL WAY

REDWOOD CITY, CA, 94063